# FDA 483 - C.G. Laboratories, Inc. - July 24, 2025

Source: https://www.keypedia.com/records/483/cg-laboratories-inc/6b1a6b87-1e31-4e6f-8803-03e728a8af11

> FDA 483 for C.G. Laboratories, Inc. on July 24, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: C.G. Laboratories, Inc.
- Inspection Date: 2025-07-24
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of C.G. Laboratories, Inc. in Granbury, TX, an HCT/Ps Testing Laboratory, revealed significant deficiencies in their quality system. The firm failed to implement adequate corrective and preventive actions, did not retain preventive maintenance records for the required duration, and lacked established procedures for critical equipment maintenance. These issues indicate a failure to meet core Current Good Tissue Practice (CGTP) requirements.

## Related Documents

- [483 - 2025-07-24](https://www.keypedia.com/records/483/cg-laboratories-inc/748c7da9-ab25-49a7-9e35-f97b78b01e1f)

## Related Officers

- [Ramon L. Gonzalez-Prieto](https://www.keypedia.com/people/ramon-l-gonzalez-prieto/f03487d2-7c8c-407f-8270-a838f7a7d127)
- [Michelle Paxon](https://www.keypedia.com/people/michelle-paxon/1748c593-7d85-4ede-a5f4-8c0a33c21d52)

Company: https://www.keypedia.com/companies/cg-laboratories-inc/55779d6e-7db5-4ed5-8037-2b1d6ee69b6f

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab